UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

In Vitro Activity of the Histatin Derivative P-113 against Multidrug-Resistant Pathogens Responsible for Pneumonia in Immunocompromised Patients

Antimicrobial Agents and Chemotherapy, 2005-03, Vol.49 (3), p.1249-1252

2005

Volltextzugriff (PDF)

RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis

Peptides (New York, N.Y. : 1980), 2005-02, Vol.26 (2), p.169-175

2005

Volltextzugriff (PDF)

In Vitro Activity and Killing Effect of Citropin 1.1 against Gram-Positive Pathogens Causing Skin and Soft Tissue Infections

Antimicrobial Agents and Chemotherapy, 2005-06, Vol.49 (6), p.2507-2509

2005

Volltextzugriff (PDF)

Use of the Quorum-Sensing Inhibitor RNAIII-Inhibiting Peptide to Prevent Biofilm Formation In Vivo by Drug-Resistant Staphylococcus epidermidis

The Journal of infectious diseases, 2003-02, Vol.187 (4), p.625-630

2003

Volltextzugriff (PDF)

Single-Dose Intraperitoneal Magainins Improve Survival in a Gram-Negative-Pathogen Septic Shock Rat Model

Antimicrobial Agents and Chemotherapy, 2002-01, Vol.46 (1), p.101-104

2002

Volltextzugriff (PDF)

RNA III Inhibiting Peptide Inhibits In Vivo Biofilm Formation by Drug-Resistant Staphylococcus aureus

Antimicrobial Agents and Chemotherapy, 2003-06, Vol.47 (6), p.1979-1983

2003

Volltextzugriff (PDF)

Efficacy of Quinupristin-Dalfopristin in Preventing Vascular Graft Infection Due to Staphylococcus epidermidis with Intermediate Resistance to Glycopeptides

Antimicrobial Agents and Chemotherapy, 2002-09, Vol.46 (9), p.2885-2888

2002

Volltextzugriff (PDF)

Potential Therapeutic Role of Cationic Peptides in Three Experimental Models of Septic Shock

Antimicrobial Agents and Chemotherapy, 2002-07, Vol.46 (7), p.2132-2136

2002

Volltextzugriff (PDF)

In vitro activity and killing effect of the synthetic hybrid cecropin A-melittin peptide CA(1-7)M(2-9)NH2 on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics

Diagnostic microbiology and infectious disease, 2004-07, Vol.49 (3), p.197-200

2004

Volltextzugriff (PDF)

In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi

Journal of antimicrobial chemotherapy, 2005-08, Vol.56 (2), p.410-412

2005

Volltextzugriff (PDF)

Combination studies between polycationic peptides and clinically used antibiotics against Gram-positive and Gram-negative bacteria

Peptides (New York, N.Y. : 1980), 2000-08, Vol.21 (8), p.1155-1160

2000

Volltextzugriff (PDF)

Short-Term Exposure to Membrane-Active Antibiotics Inhibits Cryptosporidium parvum Infection in Cell Culture

Antimicrobial Agents and Chemotherapy, 2000-12, Vol.44 (12), p.3473-3475

2000

Volltextzugriff (PDF)

Comparative activities of cecropin A, melittin, and cecropin A-melittin peptide CA(1-7)M(2-9)NH2 against multidrug-resistant nosocomial isolates of Acinetobacter baumannii

Peptides (New York, N.Y. : 1980), 2003-09, Vol.24 (9), p.1315-1318

2003

Volltextzugriff (PDF)

The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis

Critical care medicine, 2004-12, Vol.32 (12), p.2485-2490

2004

Volltextzugriff (PDF)

PREVALENCE OF INTESTINAL PARASITES AMONG INDIVIDUALS WITH ALLERGIC SKIN DISEASES

The Journal of parasitology, 2003-06, Vol.89 (3), p.490-492

2003

Volltextzugriff (PDF)

In vitro activity and killing effect of temporin A on nosocomial isolates of Enterococcus faecalis and interactions with clinically used antibiotics

Journal of antimicrobial chemotherapy, 2005-02, Vol.55 (2), p.272-274

2005

Volltextzugriff (PDF)

In vitro effect on Cryptosporidium parvum of short-term exposure to cathelicidin peptides

Journal of antimicrobial chemotherapy, 2003-04, Vol.51 (4), p.843-847

2003

Volltextzugriff (PDF)

Antimicrobial activity of polycationic peptides

Peptides (New York, N.Y. : 1980), 1999-11, Vol.20 (11), p.1265-1273

1999

Volltextzugriff (PDF)

Temporin A as a prophylactic agent against methicillin sodium-susceptible and methicillin sodium-resistant Staphylococcus epidermidis vascular graft infection

Journal of vascular surgery, 2002-11, Vol.36 (5), p.1027-1030

2002

Volltextzugriff (PDF)

Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock

Peptides (New York, N.Y. : 1980), 2003-11, Vol.24 (11), p.1747-1752

2003

Volltextzugriff (PDF)

Activity of buforin II alone and in combination with azithromycin and minocycline against Cryptosporidium parvum in cell culture

Journal of antimicrobial chemotherapy, 2001-01, Vol.47 (1), p.97-99

2001

Volltextzugriff (PDF)

In vitro activity and killing effect of the synthetic hybrid cecropin A-melittin peptide CA(1-7)M(2-9)NH(2) on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics

Diagnostic microbiology and infectious disease, 2004-07, Vol.49 (3), p.197

2004

Volltextzugriff (PDF)

In vitro activity and killing effect of the synthetic hybrid cecropin A–melittin peptide CA(1–7)M(2–9)NH 2 on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics

Diagnostic microbiology and infectious disease, 2004, Vol.49 (3), p.197-200

2004

Volltextzugriff (PDF)

Comparative activities of cecropin A, melittin, and cecropin A–melittin peptide CA(1–7)M(2–9)NH 2 against multidrug-resistant nosocomial isolates of Acinetobacter baumannii

Peptides (New York, N.Y. : 1980), 2003, Vol.24 (9), p.1315-1318

2003

Volltextzugriff (PDF)

Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock: Antimicrobial peptides. II

Peptides (New York, N.Y. : 1980), 2003, Vol.24 (11), p.1747-1752

2003

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(33)
Buchkapitel
(1)

Sprache

Englisch
(34)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(27)
Science & Technology
(27)
Biological And Medical Sciences
(19)
Animals
(18)
Medical Sciences
(17)
Pharmacology & Pharmacy
(17)
Male
(13)
Microbiology
(13)
Pharmacology. Drug Treatments
(13)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(12)
Microbial Sensitivity Tests
(11)
Anti-Bacterial Agents - Pharmacology
(10)
Humans
(10)
Infectious Diseases
(9)
Rats
(7)
Susceptibility
(7)
Biochemistry & Molecular Biology
(6)
Drug Interactions
(6)
Endocrinology & Metabolism
(6)
Rats, Wistar
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

In Vitro Activity of the Histatin Derivative P-113 against Multidrug-Resistant Pathogens Responsible for Pneumonia in Immunocompromised Patients

RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis

In Vitro Activity and Killing Effect of Citropin 1.1 against Gram-Positive Pathogens Causing Skin and Soft Tissue Infections

Use of the Quorum-Sensing Inhibitor RNAIII-Inhibiting Peptide to Prevent Biofilm Formation In Vivo by Drug-Resistant Staphylococcus epidermidis

Single-Dose Intraperitoneal Magainins Improve Survival in a Gram-Negative-Pathogen Septic Shock Rat Model

RNA III Inhibiting Peptide Inhibits In Vivo Biofilm Formation by Drug-Resistant Staphylococcus aureus

Efficacy of Quinupristin-Dalfopristin in Preventing Vascular Graft Infection Due to Staphylococcus epidermidis with Intermediate Resistance to Glycopeptides

Potential Therapeutic Role of Cationic Peptides in Three Experimental Models of Septic Shock

In vitro activity and killing effect of the synthetic hybrid cecropin A-melittin peptide CA(1-7)M(2-9)NH2 on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics

In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi

Combination studies between polycationic peptides and clinically used antibiotics against Gram-positive and Gram-negative bacteria

Short-Term Exposure to Membrane-Active Antibiotics Inhibits Cryptosporidium parvum Infection in Cell Culture

Comparative activities of cecropin A, melittin, and cecropin A-melittin peptide CA(1-7)M(2-9)NH2 against multidrug-resistant nosocomial isolates of Acinetobacter baumannii

The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis

PREVALENCE OF INTESTINAL PARASITES AMONG INDIVIDUALS WITH ALLERGIC SKIN DISEASES

In vitro activity and killing effect of temporin A on nosocomial isolates of Enterococcus faecalis and interactions with clinically used antibiotics

In vitro effect on Cryptosporidium parvum of short-term exposure to cathelicidin peptides

Antimicrobial activity of polycationic peptides

Temporin A as a prophylactic agent against methicillin sodium-susceptible and methicillin sodium-resistant Staphylococcus epidermidis vascular graft infection

Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock

Activity of buforin II alone and in combination with azithromycin and minocycline against Cryptosporidium parvum in cell culture

In vitro activity and killing effect of the synthetic hybrid cecropin A-melittin peptide CA(1-7)M(2-9)NH(2) on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics

In vitro activity and killing effect of the synthetic hybrid cecropin A–melittin peptide CA(1–7)M(2–9)NH 2 on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics

Comparative activities of cecropin A, melittin, and cecropin A–melittin peptide CA(1–7)M(2–9)NH 2 against multidrug-resistant nosocomial isolates of Acinetobacter baumannii

Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock: Antimicrobial peptides. II

Suchergebnisse filtern